205 Appendix 14. Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang CH, Hughes TF, et al. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2018;14(6):734-42. 15. Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimer’s research & therapy. 2018;10(1):15-. 16. Rodríguez-Gómez O, Abdelnour C, Jessen F, Valero S, Boada M. Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline. Journal of Alzheimer’s disease : JAD. 2015;48 Suppl 1:S99-s107. 17. van der Schaar J, Visser LNC, Bouwman FH, Ket JCF, Scheltens P, Bredenoord AL, et al. Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review. Alzheimers Res Ther. 2022;14(1):31. 18. Comijs HC, Deeg DJ, Dik MG, Twisk JW, Jonker C. Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. J Affect Disord. 2002;72(2):157-65. 19. Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013;29(4):737-52. A
RkJQdWJsaXNoZXIy MjY0ODMw